IndraLab
Statements
reach
"We hypothesized that differential catalytic activity across species may be related to substrate affinity.53 Although the catalytic site of USP18 is well conserved between mice and humans, ISG15 sequences vary.52 54 To compare interactions between USP18 and ISG15, we performed a competitive inhibition experiment with cross-species enzyme/substrate pairs."
sparser
"The association of ISG15 with USP18 interrupts the interaction of USP18 with S-phase kinase-associated protein 2 (SKP2), inhibiting the proteasomal degradation of USP18, which is essential for negative feedback regulation of IFN signaling and prevention of autoinflammation xref , xref ."
sparser
"USP18 also has enzymatic activity in removing the covalently conjugated 15kDa protein, encoded by interferon-stimulated gene 15 ( ISG15 ), from its targets in a process called de-ISGylation. xref Finally, independent of its affinity for ISGylated proteins, USP18 also binds free ISG15, which protects USP18 against proteasomal degradation, thereby enhancing its negative regulatory capacity. xref "
reach
"ISG15 is known to promote USP18-mediated inhibition of type I 437 IFN signaling by stabilizing USP18 activity and preventing its proteasomal degradation(Zhang et 438 al., 2015), underscoring the role of ISG15 as a negative regulator of type I IFN responses when 439 co-upregulated with USP18."
| DOI
reach
"ISG15 appeared to act in its unconjugated free form, since silencing of UBE1L or of other ISGylation enzymes failed to reduce USP18 levels (XREF_FIG and XREF_FIG) and patients ' cells transduced with wild-type ISG15 or ISG15 (DeltaGG) exhibited attenuated levels of interferon-stimulated-gene transcripts and proteins (XREF_FIG and XREF_FIG)."
reach
"We found that ISG15 deficiency led to reduced levels of the negative regulator USP18 because of increased proteolysis due, at least in part, to SKP2 mediated ubiquitination, resulting in stronger responses to IFN-alpha and beta and an ensuing amplification of IFN-alpha and beta-induced responses."
reach
"The coexpression of either wild-type ISG15 or ISG15 (DeltaGG) with USP18 and ubiquitin resulted in markedly lower levels of USP18 ubiquitination (XREF_FIG, lanes 9-11 and XREF_FIG) and larger total amounts of USP18.Overall, these data indicate that free intracellular ISG15 antagonizes USP18 ubiquitination and degradation, thereby promoting the stability and function of this protein."
reach
"We hypothesized that differential catalytic activity across species may be related to substrate affinity.53 Although the catalytic site of USP18 is well conserved between mice and humans, ISG15 sequences vary.52 54 To compare interactions between USP18 and ISG15, we performed a competitive inhibition experiment with cross-species enzyme/substrate pairs."
sparser
"The association of ISG15 with USP18 interrupts the interaction of USP18 with S-phase kinase-associated protein 2 (SKP2), inhibiting the proteasomal degradation of USP18, which is essential for negative feedback regulation of IFN signaling and prevention of autoinflammation xref , xref ."
sparser
"USP18 also has enzymatic activity in removing the covalently conjugated 15kDa protein, encoded by interferon-stimulated gene 15 ( ISG15 ), from its targets in a process called de-ISGylation. xref Finally, independent of its affinity for ISGylated proteins, USP18 also binds free ISG15, which protects USP18 against proteasomal degradation, thereby enhancing its negative regulatory capacity. xref "
reach
"In contrast, binding this free ISG15, USP18 suppresses JAK-STAT signaling further counteracting IFN signaling.By better understanding the ISG15 pathway, it may be possible to target certain illnesses on a case-by-case basis without the need for general activation of IFN signaling with its hundreds of downstream targets."
Arg151 affects USP18
|
1
129-135 affects USP18
|
1